CJC-1295 no DAC (Mod GRF 1-29) – Comprehensive Research Overview (2026)

CJC-1295 no DAC, also known as Modified GRF 1-29, is a synthetic 29-amino-acid analog of growth hormone-releasing hormone (GHRH). It was designed to be more stable than native GHRH while preserving strong GH-releasing activity. Unlike the long-acting CJC-1295 with DAC, the no-DAC version has a short half-life and is used to create sharp, physiologic GH pulses. It is one of the most popular research peptides in body composition, recovery, and anti-aging protocols, especially when stacked with GHRPs like Ipamorelin.

View CJC-1295 no DAC (for laboratory research use only)

Chemical Structure and Properties

  • Amino Acid Sequence: Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-NH₂ (with DPP-4 resistance modifications)
  • Molecular Weight: ≈3,368 Da
  • Form: Lyophilized powder for subcutaneous injection
  • Key Feature: Short half-life (~30 minutes) ideal for natural GH pulsing

Mechanism of Action

CJC-1295 no DAC binds to GHRH receptors on pituitary somatotrophs, activating the cAMP pathway to stimulate both GH synthesis and release.

  • Produces sharp, physiologic GH pulses rather than sustained elevation.
  • Works synergistically with ghrelin mimetics (GHRPs) to amplify GH output 2–10×.
  • Preserves natural feedback mechanisms and circadian rhythm of GH secretion.

Clinical Evidence and Research Findings

Early clinical studies demonstrated robust, dose-dependent GH pulses. While large Phase 3 trials are lacking, CJC-1295 no DAC has extensive anecdotal and clinical use in wellness and performance research. It is frequently stacked with Ipamorelin for optimal results. Benefits are most pronounced when combined with proper training, nutrition, and sleep.

→ Interested in researching CJC-1295 no DAC? View Product Options

Benefits (Research & Clinical Observations)

  • Increased lean muscle mass and strength
  • Enhanced fat loss and body composition
  • Faster recovery from training and injury
  • Improved sleep quality and skin elasticity
  • Support for overall vitality and anti-aging research

Typical Dosing Protocols (Off-Label / Compounded)

  • Common protocols: 100–200 μg per dose, 1–3 times daily (often bedtime + post-workout)
  • Most popular stack: CJC-1295 no DAC 100–150 μg + Ipamorelin 100–300 μg in the same syringe, 1–3× daily
  • Cycles: 8–12 weeks on, followed by 4+ weeks off
  • Nighttime dosing aligns best with natural GH pulses

Safety Profile and Side Effects

CJC-1295 no DAC is generally well-tolerated at research doses.

Common side effects:

  • Mild water retention
  • Injection-site reactions
  • Transient hunger (when stacked with GHRPs)

Advantages: Lower risk of sustained IGF-1 elevation side effects compared to long-acting versions or exogenous GH.

Monitoring recommended: IGF-1, fasting glucose, and insulin sensitivity with prolonged use. Contraindicated in active cancer or uncontrolled endocrine disorders.

CJC-1295 no DAC vs With DAC vs Exogenous GH – Quick Comparison

Aspect CJC-1295 no DAC CJC-1295 with DAC Exogenous GH
Half-life ~30 minutes ~6–8 days ~2–4 hours
GH Pattern Sharp, natural pulses Sustained elevation Continuous
Dosing Frequency 1–3× daily 1–2× per week Daily
Best For Physiologic pulsing Convenience High-dose anabolism
IGF-1 Elevation Pulsatile Sustained Sustained
FDA Status Not approved Not approved Approved (specific uses)


FAQ – Frequently Asked Questions

What is the difference between CJC-1295 no DAC and with DAC? No DAC creates natural GH pulses and requires more frequent dosing. With DAC provides sustained elevation with fewer injections.

Can CJC-1295 no DAC be used alone? Yes, but it is most effective when stacked with a GHRP like Ipamorelin.

How long until results are seen? GH pulses are immediate; noticeable improvements in recovery, sleep, and body composition typically appear within 2–6 weeks.

Does CJC-1295 no DAC suppress natural GH production? No. It stimulates the body’s own production and preserves natural feedback mechanisms.

Is CJC-1295 no DAC FDA approved? No. It is available only as a research chemical or through compounding pharmacies under physician supervision.

Summary

CJC-1295 no DAC is a short-acting GHRH analog prized for its ability to generate clean, physiologic GH pulses. It is widely researched and used in stacks for muscle growth, fat loss, recovery, and anti-aging protocols. While it lacks large-scale approved clinical indications, it has a long history of use with a favorable side-effect profile when dosed appropriately. As with all compounds in this library, CJC-1295 no DAC is not an approved drug and should only be considered under qualified medical supervision with appropriate lab monitoring.

For Laboratory Research Use View CJC-1295 no DAC →


Disclaimer This overview is strictly educational and based on publicly available scientific literature and regulatory information as of April 2026. It does not constitute medical advice, endorsement, or encouragement of use. Always consult a qualified healthcare professional and comply with all applicable laws and regulations.